Scientists at the Centre for Cancer Immunology alongside Cancer Research UK and Touchlight Genetics, a London based biotechnology company, have announced a new clinical development partnership to progress a therapeutic DNA vaccine, TGL-100, into an early phase clinical trial targeting head and neck squamous cell carcinoma (HNSCC).
Scientists at the Centre for Cancer Immunology, University of Southampton, have discovered a way to transform antibody drugs previously developed to treated autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.
Professor Tim Elliott, Director for the Centre for Cancer Immunology, provides an update on Centre activity during the COVID-19 outbreak.
A simple lab-based blood test could potentially identify which cancer patients would get harmful side-effects from antibody immunotherapy treatment, a new Southampton study has shown.
A new research programme led by scientists at the Centre for Cancer Immunology will give important insight into an integral part of our immune system and the fight against cancer.
Scientists at the Centre for Cancer Immunology have been awarded £2.2million to develop the next generation of targeted therapy used to treat some cancers.
Centre Director Professor Tim Elliott takes a look back at 2018 – a pivotal year for the Centre for Cancer Immunology, its staff and the patients it was built to help.
A scientist at the Centre for Cancer Immunology has been awarded £1.65million to expand her research into ways the immune system can be harnessed and boosted to destroy cancer cells.
Scientists at the Centre for Cancer Immunology have played key roles in immunology research recognised by the 2018 Nobel Prize committee.
Scientists at the Centre have developed a new antibody that could hold the key to unlocking cancer’s defence against the body’s immune system.